As our in vitro results (in bronchial epithelial cells) demonstrated that LL-37 can modulate IL-17-mediated airway inflammation by influencing processes related to neutrophil recruitment, we next examined the abundance of protein targets selected from our in vitro studies in a mouse model of neutrophilic airway inflammation [6] (Supplemental Fig. 6A). This evidence concerns the gene IL17A and inflammatory response.